MA is a factor leading to a decrease in the level of 1,25-dihydroxyvitamin D3 (calcitriol) in serum and an increase in parathyroid hormone (secondary hyperparathyroidism) and FGF23. Here, FGF23 is linked to secondary hyperparathyroidism.